.png){kind=icon}
.png){kind=icon}
Return
Plant-derived exosome-like nanovesicles alleviate testicular injury by suppressing p21-mediated cell cycle arrest in Sertoli cells
.png){kind=icon}
OA
AI
Y
X
C
M
W
P
X
Y
DOI：10.1186/s12951-026-04871-8.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Testicular dysfunction represents a leading cause of male infertility, yet effective therapeutic interventions remain elusive. Here, we report a novel plant-derived nanotherapeutic strategy for testicular injury using Cistanche deserticola-derived exosome-like nanovesicles (CDELNs). CDELNs are preferentially internalized by testicular Sertoli cells via heparan sulfate proteoglycan (HSPG)-mediated endocytosis, whereupon, CDELN-derived miR-159b-3p directly targets the 3’UTR of Cdkn1a mRNA, leading to downregulation of p21 and subsequent alleviation of p21-mediated cell cycle arrest in Sertoli cells. In a mouse model of testicular injury, administration of CDELNs significantly ameliorated testicular histopathology, restored blood-testis barrier integrity, improved sperm quality and key hormone levels, and partially rescued fertility. Notably, reanalysis of publicly available single-cell RNA-seq data from non-obstructive azoospermia (NOA) patients revealed elevated CDKN1A expression in Sertoli cells, suggesting that p21 dysregulation may also contribute to human testicular dysfunction. In summary, our study supports CDELNs as a natural nanovesicle-based candidate that protects against testicular injury through miRNA-mediated p21 suppression, offering a promising translational avenue for male infertility.
Keywords:
Testicular injury
Cistanche deserticola-derived exosome-like nanovesicles (CDELNs)
miR-159b-3p
p21
Cell cycle
Sertoli cells
Journal
IF:
12.6
Papers:
5.0K
Citations:
2.8W
Organization
Cited Papers